Author

Pilar Ballesteros-Cuartero

Centro Nacional de Biotecnología, Consejo Superior de Investigaciones CientíficasPrimary ORCID profile (0009-0006-1240-6376 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Pilar Ballesteros-CuarteroiD2 papers · ETH Zurich

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Almudena Mendez-Perez· 1 shared Andres M Acosta-Moreno· 1 shared Arrate Munoz-BarrutiaiD· 1 shared Carlos Oscar Sorzano· 1 shared Carlos Wert-CarvajaliD· 1 shared Esteban VeigaiD· 1 shared Jose R Macias· 1 shared Ramon Alemany· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Almudena Mendez-Perez

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivNov 22, 2023

Unraveling the Power of NAP-CNB's Machine Learning-enhanced Tumor Neoantigen Prediction

Almudena Mendez-Perez, Andres M Acosta-Moreno, Carlos Wert-Carvajal…·Esteban Veiga

This study validates a machine learning platform, NAP-CNB, for identifying tumor neoantigens using RNAseq data, showing improved antitumor responses with multiantigen vaccination.

DOI 10.7554/elife.95010

humanbulk RNA-seq

𝕏 PostBluesky